Magnetic field enhancement of tumor treatment
US6679827B2 · kind B2 · utility
14Cited by
27References
16Claims
0Family size
Inventor
Key dates
| Filing date | Oct 9, 2002 |
| Grant date | Jan 20, 2004 |
| Priority date | — |
| Expiry date | Oct 9, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61N5/10
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
A method of creating an elevated concentration of free radicals having augmented lifetimes within a tumor, that includes creating an elevated concentration of free radicals in the tumor and creating a magnetic field that traverses the tumor and that inhibits the recombination of the free radicals in the tumor. A magnetic field of 0.1 mTesla to 10 mTesla is generally used for this purpose.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.